Axon Enterprise, Inc. (NASDAQ:AXON) Shares Acquired by Mackenzie Financial Corp

Mackenzie Financial Corp increased its holdings in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 14.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 7,181 shares of the biotechnology company's stock after purchasing an additional 928 shares during the quarter. Mackenzie Financial Corp's holdings in Axon Enterprise were worth $4,268,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of AXON. Fourth Dimension Wealth LLC acquired a new position in shares of Axon Enterprise during the fourth quarter valued at about $30,000. New Wave Wealth Advisors LLC purchased a new stake in Axon Enterprise in the 4th quarter valued at about $40,000. Y.D. More Investments Ltd purchased a new stake in Axon Enterprise in the 4th quarter valued at about $45,000. Elequin Capital LP bought a new position in shares of Axon Enterprise during the 4th quarter valued at approximately $46,000. Finally, Stonebridge Financial Group LLC bought a new position in shares of Axon Enterprise during the 4th quarter valued at approximately $53,000. Institutional investors own 79.08% of the company's stock.

Insider Activity

In other Axon Enterprise news, Director Jeri Williams sold 307 shares of the company's stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the transaction, the director now owns 1,627 shares in the company, valued at approximately $899,275.44. This represents a 15.87% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of the company's stock in a transaction on Monday, April 21st. The shares were sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the completion of the sale, the chief executive officer now directly owns 3,063,982 shares in the company, valued at $1,657,583,622.18. This trade represents a 0.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 34,969 shares of company stock worth $23,127,314. 5.70% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of research analysts recently weighed in on the stock. Barclays lifted their price objective on shares of Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a research note on Friday, May 9th. Craig Hallum lowered shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a research note on Monday, March 10th. The Goldman Sachs Group lifted their price objective on shares of Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a research note on Wednesday, May 14th. JMP Securities reiterated an "outperform" rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. Finally, Northcoast Research lowered shares of Axon Enterprise from a "buy" rating to a "neutral" rating in a research note on Wednesday, February 19th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and ten have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $652.73.

Axon Enterprise Stock Performance

AXON traded up $13.34 during trading on Friday, hitting $743.63. The company's stock had a trading volume of 1,121,061 shares, compared to its average volume of 732,673. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a one year low of $273.52 and a one year high of $755.05. The firm has a market cap of $57.89 billion, a PE ratio of 192.15, a P/E/G ratio of 5.17 and a beta of 1.24. The business's 50 day simple moving average is $620.57 and its 200-day simple moving average is $610.50.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, topping the consensus estimate of $1.34 by $0.07. The business had revenue of $603.63 million for the quarter, compared to the consensus estimate of $585.67 million. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. The company's quarterly revenue was up 31.3% on a year-over-year basis. During the same period last year, the firm earned $1.15 earnings per share. As a group, sell-side analysts predict that Axon Enterprise, Inc. will post 5.8 EPS for the current fiscal year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.